RxDoctor Payments Data

Tania Falcon Rodriguez, MD

General Practice · Orlando, FLNPI 1497859722

Payments from drug & device makers

$282in general payments, 2019–2025

Across 14 payments — averaging $20.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$66
  • Bayer$53
  • Abbott$37
  • Lilly USA, LLC$34
  • Astellas Pharma US Inc$23
  • AstraZeneca$18
  • plus $51 from 3 others

What the payments were for

  • Food & beverage$282100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$282 in reported general payments places this provider in the 50th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida

Medicare billing

Part B allowed, 2024
$5,255
Medicare patients
17
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol67$76,646
OzempicSemaglutide51$75,623
EliquisApixaban39$53,266
JardianceEmpagliflozin28$40,100
JanuviaSitagliptin Phosphate13$19,843
Atorvastatin Calcium411$4,691
LantusInsulin Glargine,hum.Rec.Anlog27$4,039
Rosuvastatin Calcium181$3,658
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$3,605
SynthroidLevothyroxine Sodium28$2,520
Levothyroxine Sodium233$2,233
Losartan Potassium240$2,162
Gabapentin118$1,925
Ezetimibe70$1,857
Albuterol Sulfate HfaAlbuterol Sulfate98$1,586

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$18$76,64667 claims
Novo NordiskOzempic$18$75,62351 claims
Boehringer IngelheimJardiance$66$40,10028 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 6,901 general practice providers in Florida.

Other general practice in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →